207 related articles for article (PubMed ID: 34884344)
1. Therapeutic Drug Monitoring of Biologics in IBD: Essentials for the Surgical Patient.
Nones RB; Fleshner PR; Queiroz NSF; Cheifetz AS; Spinelli A; Danese S; Peyrin-Biroulet L; Papamichael K; Kotze PG
J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884344
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Drug Monitoring of Biologics in Crohn's Disease.
Grossberg LB; Cheifetz AS; Papamichael K
Gastroenterol Clin North Am; 2022 Jun; 51(2):299-317. PubMed ID: 35595416
[TBL] [Abstract][Full Text] [Related]
3. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
4. Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.
Papamichael K; Cheifetz AS; Melmed GY; Irving PM; Vande Casteele N; Kozuch PL; Raffals LE; Baidoo L; Bressler B; Devlin SM; Jones J; Kaplan GG; Sparrow MP; Velayos FS; Ullman T; Siegel CA
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1655-1668.e3. PubMed ID: 30928454
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Drug Monitoring in Perianal Fistulizing Crohn's Disease.
Zulqarnain M; Deepak P; Yarur AJ
J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407421
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease.
Carman N; Mack DR; Benchimol EI
Curr Gastroenterol Rep; 2018 Apr; 20(5):18. PubMed ID: 29623442
[TBL] [Abstract][Full Text] [Related]
7. Does perioperative biological therapy increase 30-day post-operative complication rates in inflammatory bowel disease patients undergoing intra-abdominal surgery? A systematic review.
Byrne LW; McKay D
Surgeon; 2021 Oct; 19(5):e153-e167. PubMed ID: 34581275
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of blood concentration of biologics on endoscopic inactivity in inflammatory bowel disease: A systematic review.
Cao WT; Huang R; Jiang KF; Qiao XH; Wang JJ; Fan YH; Xu Y
World J Gastroenterol; 2021 Mar; 27(9):886-907. PubMed ID: 33727776
[TBL] [Abstract][Full Text] [Related]
9. Biologics and 30-Day Postoperative Complications After Abdominal Operations for Crohn's Disease: Are There Differences in the Safety Profiles?
Lightner AL; McKenna NP; Alsughayer A; Harmsen WS; Taparra K; Parker ME; Raffals LE; Loftus EV
Dis Colon Rectum; 2019 Nov; 62(11):1352-1362. PubMed ID: 31567927
[TBL] [Abstract][Full Text] [Related]
10. Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study.
Poylin VY; Serrato JC; Pastrana Del Valle J; Feuerstein JD
Intest Res; 2022 Jan; 20(1):72-77. PubMed ID: 33525861
[TBL] [Abstract][Full Text] [Related]
11. Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease.
Lightner AL; Raffals LE; Mathis KL; Cima RR; Tse CS; Pemberton JH; Dozois EJ; Loftus EV
J Crohns Colitis; 2017 Feb; 11(2):185-190. PubMed ID: 27543504
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive review and update on Crohn's disease.
Gajendran M; Loganathan P; Catinella AP; Hashash JG
Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
[TBL] [Abstract][Full Text] [Related]
13. Biologics in inflammatory bowel disease: what are the data?
Côté-Daigneault J; Bouin M; Lahaie R; Colombel JF; Poitras P
United European Gastroenterol J; 2015 Oct; 3(5):419-28. PubMed ID: 26535119
[TBL] [Abstract][Full Text] [Related]
14. Advances in Therapeutic Drug Monitoring for Small-Molecule and Biologic Therapies in Inflammatory Bowel Disease.
Ma C; Battat R; Jairath V; Vande Casteele N
Curr Treat Options Gastroenterol; 2019 Mar; 17(1):127-145. PubMed ID: 30680599
[TBL] [Abstract][Full Text] [Related]
15. Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu.
García MJ; Rivero M; Miranda-Bautista J; Bastón-Rey I; Mesonero F; Leo-Carnerero E; Casas-Deza D; Cagigas Fernández C; Martin-Cardona A; El Hajra I; Hernández-Aretxabaleta N; Pérez-Martínez I; Fuentes-Valenzuela E; Jiménez N; Rubín de Célix C; Gutiérrez A; Suárez Ferrer C; Huguet JM; Fernández-Clotet A; González-Vivó M; Del Val B; Castro-Poceiro J; Melcarne L; Dueñas C; Izquierdo M; Monfort D; Bouhmidi A; Ramírez De la Piscina P; Romero E; Molina G; Zorrilla J; Calvino-Suárez C; Sánchez E; Nuñez A; Sierra O; Castro B; Zabana Y; González-Partida I; De la Maza S; Castaño A; Nájera-Muñoz R; Sánchez-Guillén L; Riat Castro M; Rueda JL; Benítez JM; Delgado-Guillena P; Tardillo C; Peña E; Frago-Larramona S; Rodríguez-Grau MC; Plaza R; Pérez-Galindo P; Martínez-Cadilla J; Menchén L; Barreiro-De Acosta M; Sánchez-Aldehuelo R; De la Cruz MD; Lamuela LJ; Marín I; Nieto-García L; López-San Román A; Herrera JM; Chaparro M; Gisbert JP; On Behalf Of The Young Group Of Geteccu
J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640421
[TBL] [Abstract][Full Text] [Related]
16. Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease.
Barré A; Colombel JF; Ungaro R
Aliment Pharmacol Ther; 2018 Apr; 47(7):896-905. PubMed ID: 29430672
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug monitoring in inflammatory bowel disease: At the right time in the right place.
Truta B
World J Gastroenterol; 2022 Apr; 28(13):1380-1383. PubMed ID: 35645545
[TBL] [Abstract][Full Text] [Related]
18. Superior treatment persistence with ustekinumab in Crohn's disease and vedolizumab in ulcerative colitis compared with anti-TNF biological agents: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study.
Ko Y; Paramsothy S; Yau Y; Leong RW
Aliment Pharmacol Ther; 2021 Aug; 54(3):292-301. PubMed ID: 34151447
[TBL] [Abstract][Full Text] [Related]
19. Proactive versus Reactive Therapeutic Drug Monitoring: Why, When, and How?
Shmais M; Regueiro M; Hashash JG
Inflamm Intest Dis; 2022 Jan; 7(1):50-58. PubMed ID: 35224018
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
